DiSanto; Anthony R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for DiSanto; Anthony R..The latest application filed is for "intranasally administered antihistamines and uses thereof".

Company Profile

1.7.16

DiSanto; Anthony R. - Gobles MI
DiSanto; Anthony R. - Dade City FL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Intranasally Administered Antihistamines And Uses Thereof App 20220160656 - Sramek; John ; et al.	2022-05-26
Intranasally Administered Antihistamines And Uses Thereof App 20200297623 - Sramek; John ; et al.	2020-09-24
S(+) desmethylselegiline and its use to treat narcolepsy Grant 7,144,584 - DiSanto December 5, 2	2006-12-05
Methods for treating cerebrovascular disease by administering desmethylselegiline App 20060167110 - Blume; Cherly D. ; et al.	2006-07-27
S(+) desmethylselegiline and its use to treat narcolepsy App 20040241220 - DiSanto, Anthony R.	2004-12-02
Methods and pharmaceutical compositions employing desmethylselegiline App 20040228907 - Blume, Cheryl D. ; et al.	2004-11-18
S(+) Desmethylselegiline and its use to treat ADHD Grant 6,759,053 - DiSanto July 6, 2	2004-07-06
Methods for treating multiple sclerosis employing desmethylselegiline Grant 6,699,495 - Blume , et al. March 2, 2	2004-03-02
Methods for treating multiple sclerosis employing desmethylselegiline App 20030194432 - Blume, Cheryl D. ; et al.	2003-10-16
Methods and pharmaceutical compositions employing S(+)-desmethylselegiline to treat neoplastic diseases or conditions App 20030195260 - DiSanto, Anthony R.	2003-10-16
Methods for preventing and treating peripheral neuropathy by administering desmethylselegiline delivery compositions App 20030191191 - Blume, Cheryl D. ; et al.	2003-10-09
S(+) desmethylselegiline and its use to treat ADHD App 20030153624 - DiSanto, Anthony R.	2003-08-14
Desmethylselegiline enantiomers and their use to treat drug withdrawal symptoms Grant 6,562,364 - DiSanto , et al. May 13, 2	2003-05-13
S(+) desmethylselegiline and drug withdrawal Grant 6,420,433 - DiSanto July 16, 2	2002-07-16
Methods employing R(-)-desmethylselegiline App 20020064552 - Blume, Cheryl D. ; et al.	2002-05-30
Methods and pharmaceutical compositions employing desmethylselegiline to treat neoplastic diseases or conditions App 20020037930 - Blume, Cheryl D. ; et al.	2002-03-28
R(-) desmethylselegiline and its use in transdermal delivery compositions App 20010056126 - Blume, Cheryl D. ; et al.	2001-12-27
S(+) desmethylselegiline and drug withdrawal App 20010053798 - Disanto, Anthony R.	2001-12-20
S(+) desmethylselegiline and its use in transdermal delivery compositions App 20010044473 - DiSanto, Anthony R.	2001-11-22
S-(+)-desmethylselegiline and its use in the therapeutic methods and pharmaceutical compositions Grant 6,319,954 - DiSanto November 20, 2	2001-11-20
S(+) desmethylselegiline and its use to treat immune system dysfunction App 20010041747 - DiSanto, Anthony R.	2001-11-15
Desmethylselegiline enantiomers and their use to treat drug withdrawal symptoms App 20010018457 - DiSanto, Anthony R. ; et al.	2001-08-30
Sublingual and buccal administration of selegiline for treating certain selegiline-responsive diseases and conditions Grant 6,117,912 - DiSanto September 12, 2	2000-09-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.